The life science and clinical data transparency industry must take a collaborative approach to achieve data disclosure compliance to combat the burden of new regulatory requirements and renewed infrastructure needs. Within these new regulatory changes, both the U.S and global level develop strategies to release patient-level data and anonymous data to achieve meaningful patient engagement.

At ExL’s 3rd Disclosure and Transparency for Clinical Data Summit attendees will gain comprehensive, high-quality education that balances commercial values and ethical responsibility through the execution of national and global data transparency.